Holen Sie sich die Stockscreener-App
7.71
4.47%
0.33
Handel nachbörslich:
7.70
-0.010
-0.13%
Schlusskurs vom Vortag:
$7.38
Offen:
$7.44
24-Stunden-Volumen:
467.83K
Relative Volume:
0.45
Marktkapitalisierung:
$476.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-130.41M
KGV:
-3.442
EPS:
-2.24
Netto-Cashflow:
$-67.76M
1W Leistung:
+2.80%
1M Leistung:
+60.63%
6M Leistung:
+96.68%
1J Leistung:
+54.20%
1-Tages-Spanne:
$7.435
$7.77
1-Wochen-Bereich:
$7.235
$7.8712
52-Wochen-Spanne:
$3.5001
$12.40
Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile
Firmenname
Monte Rosa Therapeutics Inc
Sektor
Branche
Telefon
617-949-2643
Adresse
321 HARRISON AVENUE, BOSTON
Vergleichen Sie GLUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLUE
Monte Rosa Therapeutics Inc
|
7.71 | 455.78M | 0 | -130.41M | -67.76M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-02-15 | Eingeleitet | Wedbush | Outperform |
| 2023-01-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-13 | Eingeleitet | UBS | Buy |
| 2022-08-15 | Eingeleitet | Jefferies | Buy |
| 2022-04-28 | Eingeleitet | Credit Suisse | Neutral |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-10-14 | Eingeleitet | SVB Leerink | Mkt Perform |
Alle ansehen
Monte Rosa Therapeutics Inc Aktie (GLUE) Neueste Nachrichten
Monte Rosa Therapeutics Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
Will Monte Rosa Therapeutics Inc. see short term momentum2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Comparing Monte Rosa Therapeutics Inc. in custom built stock radarsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
How high can Monte Rosa Therapeutics Inc. stock goShort Setup & Advanced Technical Analysis Signals - newser.com
Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects - Insider Monkey
11 Best Fast Money Stocks to Buy Now - Insider Monkey
Is Monte Rosa Therapeutics Inc a good long term investmentGeopolitical Risk Analysis & Consistent Double Returns - earlytimes.in
Monte Rosa Therapeutics Inc Stock Analysis and ForecastLarge Cap Stability Picks & Fast Profit Trading Ideas - earlytimes.in
Full technical analysis of Monte Rosa Therapeutics Inc. stockBuy Signal & Accurate Buy Signal Notifications - newser.com
Is Monte Rosa Therapeutics Inc. stock reversal real or fakeWatch List & Daily Chart Pattern Signals - newser.com
Monte Rosa Therapeutics Inc. stock trend forecastJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
Pallas Capital Advisors LLC Makes New $59,000 Investment in Monte Rosa Therapeutics, Inc. $GLUE - Defense World
Monte Rosa Therapeutics presents new CDK2 degradation inducers - BioWorld MedTech
Monte Rosa Is Building The ‘Next RNAi’ Through AI-Powered Molecular Glue Discovery - insights.citeline.com
Will Monte Rosa Therapeutics Inc. stock go up soonJuly 2025 Fed Impact & Community Consensus Picks - newser.com
Sentiment analysis tools applied to Monte Rosa Therapeutics Inc.July 2025 Big Picture & Stepwise Entry and Exit Trade Signals - newser.com
Q3 EPS Forecast for Monte Rosa Therapeutics Cut by Analyst - MarketBeat
Aug EndMonth: Can Monte Rosa Therapeutics Inc disrupt its industryPortfolio Value Summary & Free High Accuracy Swing Entry Alerts - خودرو بانک
Market Moves: Can Monte Rosa Therapeutics Inc. disrupt its industry2025 Retail Activity & Growth Oriented Trading Recommendations - خودرو بانک
Is a relief rally coming for Monte Rosa Therapeutics Inc. holders2025 Volatility Report & Safe Entry Momentum Tips - newser.com
Pattern recognition hints at Monte Rosa Therapeutics Inc. upside2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Is Monte Rosa Therapeutics Inc a potential multi baggerMarket Activity Report & Free High Return Stock Watch Alerts - خودرو بانک
Will Monte Rosa Therapeutics Inc benefit from seasonalityJuly 2025 Market Mood & Smart Swing Trading Alerts - خودرو بانک
Gains Report: Is Monte Rosa Therapeutics Inc stock a good pick for beginnersWeekly Loss Report & Daily Technical Stock Forecast Reports - khodrobank.com
Can momentum traders help lift Monte Rosa Therapeutics Inc.Earnings Miss & Daily Profit Focused Stock Screening - newser.com
EV Market: Why is Solid Biosciences Inc stock going up2025 Top Decliners & High Return Trade Opportunity Guides - khodrobank.com
Risk adjusted return profile for Monte Rosa Therapeutics Inc. analyzedQuarterly Portfolio Review & Weekly High Potential Alerts - newser.com
EV Market: Is Monte Rosa Therapeutics Inc stock a good pick for beginnersWeekly Investment Report & Low Drawdown Trading Strategies - خودرو بانک
Visual analytics tools that track Monte Rosa Therapeutics Inc. performance2025 Buyback Activity & Target Return Focused Picks - newser.com
Analyst Upgrade: Can Monte Rosa Therapeutics Inc lead its sector in growthWeekly Trade Summary & Reliable Price Action Trade Plans - خودرو بانک
Analysis Recap: Is Monte Rosa Therapeutics Inc stock a hidden gemMarket Risk Report & Intraday High Probability Alerts - خودرو بانک
Monte Rosa: H1 2026 NEK7 Protein Degrader MRT-8102 Data Could Be Added POC - Seeking Alpha
Will Monte Rosa Therapeutics Inc. stock recover after recent dropWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
Meme Stocks: Will Clene Inc. Equity Warrant benefit from government policyDip Buying & Reliable Price Breakout Signals - خودرو بانک
CEO Moves: Will Monte Rosa Therapeutics Inc. benefit from geopolitical trendsTreasury Yields & Proven Capital Preservation Methods - خودرو بانک
Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
4.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):